2 Monster Growth Stocks with Huge Potential in 2024 by Mark Eisenberg 08.04.2024 Consider investing in AbbVie and e.l.f., two names with significant growth potential in 2024. AbbVie shines as a quality business ...
BioVaxys Acquires IMV’s Immunotherapy Tech for Growth by John Darbie 13.02.2024 BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...
Anixa’s Ovarian Cancer Trial Progress: Promising Results by Terry Bingman 12.02.2024 Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...